Evidence map›Paper›PMID 34789016›Full record

ArticleCirculation research2022

VE-Cadherin Is Required for Cardiac Lymphatic Maintenance and Signaling.

Natalie R Harris, Natalie R Nielsen, John B Pawlak, Amir Aghajanian, Krsna Rangarajan, D Stephen Serafin, Gregory Farber, Danielle M Dy, Nathan P Nelson-Maney, Wenjing Xu and 5 more

Open access · greenAbstract read
In one paragraph

Article in Circulation research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 1 pooled it
2.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 1 synthesis or guideline pooled it, 48 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Metabolic Syndrome-Driven Changes in Cardiac Lymphatic Endothelium: mRNA Expression and Emerging Questions.Pathophysiology : the official journal of the International Society for Pathophysiology · 2026
    Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Regulation of VEGFR3 signaling in lymphatic endothelial cells.Frontiers in cell and developmental biology · 2025
    Review
  14. Cardiac lymphatics undergo distinct remodeling during hypertrophic and nonhypertrophic pregnancy.American journal of physiology. Heart and circulatory physiology · 2024
    Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Research progress in the cardiac lymphatic system and myocardial repair after myocardial infarction.Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences · 2023
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 2 countries.

Natalie R HarrisDepartment of Cell Biology and Physiology (N.R.H., N.R.N., J.B.P., K.R., D.S.S., D.M.D., N.P.N.-M., W.X., D.R., S.H.H., K.M.C.), University of North Carolina at Chapel Hill.
Natalie R NielsenDepartment of Cell Biology and Physiology (N.R.H., N.R.N., J.B.P., K.R., D.S.S., D.M.D., N.P.N.-M., W.X., D.R., S.H.H., K.M.C.), University of North Carolina at Chapel Hill.
John B PawlakDepartment of Cell Biology and Physiology (N.R.H., N.R.N., J.B.P., K.R., D.S.S., D.M.D., N.P.N.-M., W.X., D.R., S.H.H., K.M.C.), University of North Carolina at Chapel Hill.ORCID 0000-0002-2407-2944
Amir AghajanianDepartment of Medicine Division of Cardiology (A.A.), University of North Carolina at Chapel Hill.ORCID 0000-0002-3671-7957
Krsna RangarajanDepartment of Cell Biology and Physiology (N.R.H., N.R.N., J.B.P., K.R., D.S.S., D.M.D., N.P.N.-M., W.X., D.R., S.H.H., K.M.C.), University of North Carolina at Chapel Hill.
D Stephen SerafinDepartment of Cell Biology and Physiology (N.R.H., N.R.N., J.B.P., K.R., D.S.S., D.M.D., N.P.N.-M., W.X., D.R., S.H.H., K.M.C.), University of North Carolina at Chapel Hill.
Gregory FarberDepartment of Pathology and Laboratory Medicine (G.F., L.Q.), University of North Carolina at Chapel Hill.
Danielle M DyDepartment of Cell Biology and Physiology (N.R.H., N.R.N., J.B.P., K.R., D.S.S., D.M.D., N.P.N.-M., W.X., D.R., S.H.H., K.M.C.), University of North Carolina at Chapel Hill.ORCID 0000-0002-9330-4761
Nathan P Nelson-ManeyDepartment of Cell Biology and Physiology (N.R.H., N.R.N., J.B.P., K.R., D.S.S., D.M.D., N.P.N.-M., W.X., D.R., S.H.H., K.M.C.), University of North Carolina at Chapel Hill.ORCID 0000-0002-9388-2801
Wenjing XuDepartment of Cell Biology and Physiology (N.R.H., N.R.N., J.B.P., K.R., D.S.S., D.M.D., N.P.N.-M., W.X., D.R., S.H.H., K.M.C.), University of North Carolina at Chapel Hill.
Disha RatraDepartment of Cell Biology and Physiology (N.R.H., N.R.N., J.B.P., K.R., D.S.S., D.M.D., N.P.N.-M., W.X., D.R., S.H.H., K.M.C.), University of North Carolina at Chapel Hill.
Sophia H HurrDepartment of Cell Biology and Physiology (N.R.H., N.R.N., J.B.P., K.R., D.S.S., D.M.D., N.P.N.-M., W.X., D.R., S.H.H., K.M.C.), University of North Carolina at Chapel Hill.
Li QianDepartment of Pathology and Laboratory Medicine (G.F., L.Q.), University of North Carolina at Chapel Hill.ORCID 0000-0001-7614-5618
Joshua P ScallanDepartment of Molecular Pharmacology and Physiology, University of South Florida, Tampa (J.P.S.).
Kathleen M CaronDepartment of Cell Biology and Physiology (N.R.H., N.R.N., J.B.P., K.R., D.S.S., D.M.D., N.P.N.-M., W.X., D.R., S.H.H., K.M.C.), University of North Carolina at Chapel Hill.ORCID 0000-0002-7033-9232
Norwegian Womens Public Health Association · NOUniversity of North Carolina at Chapel Hill · USUniversity of South Florida · US

Funding

Virology Research Program (Program 4)P30CA016086 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI David Darr · 1985 to 2026
$201.5M
UNC Neuroscience Center Research Cores: MicroscopyP30NS045892 · NINDS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI ZYLKA, MARK J. · 2003 to 2022
$11.5M
Pre-doctoral Training Program in Integrative Vascular BiologyT32HL069768 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Christopher P. Mack · 2002 to 2026
$9.7M
Preclinical CoreU54HD079124 · NICHD · UNIV OF NORTH CAROLINA CHAPEL HILL · PI BELGER, AYSENIL · 2013 to 2019
$8.0M
Altering Cardiac Cell Fate for Heart RepairR35HL155656 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Li Qian · 2021 to 2026
$5.5M
CANCER CELL BIOLOGY TRAINING PROGRAMT32CA071341 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI CHANNING J. DER, Yuliya Pylayeva-Gupta · 1996 to 2026
$5.0M
Cardiac Lymphatics in Heart FailureR01HL129086 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI CARON, KATHLEEN M · 2016 to 2023
$4.1M
GPCR-mediated pathways for regulation of intestinal lymphatic functionR01DK119145 · NIDDK · UNIV OF NORTH CAROLINA CHAPEL HILL · PI CARON, KATHLEEN M · 2019 to 2023
$2.6M
Pathways Regulating Lymphatic Vessel Permeability and Valve FormationR01HL142905 · NHLBI · UNIVERSITY OF SOUTH FLORIDA · PI SCALLAN, JOSHUA PAUL · 2019 to 2023
$2.2M
Training Program in Cellular Systems and Integrative PhysiologyT32GM133364 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Kathleen M Caron, Natasha T Snider · 2020 to 2026
$1.4M
Adrenomedullin Signaling in Vascular DevelopmentR01HL091973 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI CARON, KATHLEEN M · 2008 to 2011
$1.4M
Cardiac Lymphatics in the Resolution of Myocardial EdemaF31HL143836 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI NIELSEN, NATALIE ROSE · 2018 to 2020
$73k
NCI NIH HHS P30 CA016086NCI NIH HHS T32 CA071341NHLBI NIH HHS F31 HL143836NHLBI NIH HHS R01 HL091973NHLBI NIH HHS R01 HL129086NHLBI NIH HHS R01 HL142905NHLBI NIH HHS R35 HL155656NHLBI NIH HHS T32 HL069768NICHD NIH HHS U54 HD079124NIDDK NIH HHS R01 DK119145NIGMS NIH HHS T32 GM133364NINDS NIH HHS P30 NS045892
6 · The paper itself

Abstract

backgroundThe adherens protein VE-cadherin (vascular endothelial cadherin) has diverse roles in organ-specific lymphatic vessels. However, its physiological role in cardiac lymphatics and its interaction with lymphangiogenic factors has not been fully explored. We sought to determine the spatiotemporal functions of VE-cadherin in cardiac lymphatics and mechanistically elucidate how VE-cadherin loss influences prolymphangiogenic signaling pathways, such as adrenomedullin and VEGF (vascular endothelial growth factor)-C/VEGFR3 (vascular endothelial growth factor receptor 3) signaling.

methods

resultsEmbryonic deletion of VE-cadherin produced edematous embryos with dilated cardiac lymphatics with significantly altered vessel tip morphology. Postnatal deletion of VE-cadherin caused complete disassembly of cardiac lymphatics. Adult deletion caused a temporal regression of the quiescent epicardial lymphatic network which correlated with significant dermal and cardiac lymphatic dysfunction, as measured by fluorescent and quantum dot lymphangiography, respectively. Surprisingly, despite regression of cardiac lymphatics,

conclusionsVE-cadherin is an essential scaffolding protein to maintain prolymphangiogenic signaling nodes at the plasma membrane, which are required for the development and adult maintenance of cardiac lymphatics, but not for cardiac function basally or after injury.

Indexed as

Signal TransductionAnimalsAntigens, CDCadherin 5CadherinsCells, CulturedFemaleHumansLymphatic VesselsMaleMiceMice, Inbred C57BLPericardiumVascular Endothelial Growth Factor AVascular Endothelial Growth Factor Receptor-3Antigens, CDCadherin 5CadherinsVascular Endothelial Growth Factor AVascular Endothelial Growth Factor Receptor-3adrenomedullincadherinsendothelial cellsmyocardial infarctionvascular endothelial growth factor receptor

Identifiers

PMID34789016
PMCPMC8756423
OpenAlexW3212857946

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.